Phase 1 Absorption Distribution Metabolism and Excretion of AQX-1125
Clinical trial NCT03185195 · COMPLETED
Trial details
- NCT number
- NCT03185195
- Sponsor
- Aquinox Pharmaceuticals (Canada) Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-22
- Primary completion
- 2017-01-04
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.